Vectus Biosystems Limited (ASX:VBS) Releases December 2024 Quarterly Activities Report
Vectus Biosystems Limited (ASX:VBS) releases its December 2024 Quarterly Activities Report, detailing clinical trial progress and a strong financial position.
Lincoln Minerals Limited (ASX:LML) Announces December 2024 Quarterly Activities
Lincoln Minerals Limited (ASX:LML) announces December 2024 quarterly activities, focusing on project advancements and cost reduction strategies.
Andromeda Metals (ASX:ADN) Advances Great White Project with Funding Progress and Tax Incentives
Andromeda Metals (ASX:ADN) reports Q4 progress on the Great White Project, highlighting funding advancements and government tax incentives.
Globe Metals & Mining (ASX:GBE) Advances Kanyika Project with $10M IDC Funding and $1.2M Additional Loan
Globe Metals & Mining (ASX:GBE) advances its Kanyika Niobium Project with $10 million funding from IDC and secures an additional $1.2 million loan.
Kula Gold Limited (ASX:KGD) Announces Results of Entitlement Offer
Kula Gold (ASX:KGD) announces the results of its entitlement offer, issuing 66,441,764 new shares and outlining future share issuance plans.
Accelerate Resources (ASX:AX8) Announces A$1.35M Capital Raising
Accelerate Resources (ASX:AX8) secures A$1.35M to advance its gold strategy and exploration activities.
Australian Pacific Coal Limited (ASX:AQC) Releases Quarterly Activities Report
Australian Pacific Coal Limited (ASX:AQC) reports first commercial coal rail, production ramp-up, and financing achievements in Q4 2024 activities report.
Peninsula Energy Limited (ASX:PEN) Restarts Lance Uranium Production and Appoints New CEO
Peninsula Energy Limited (ASX:PEN) restarts Lance uranium production and appoints a new CEO, strengthening its position as an independent uranium producer.
Peninsula Energy Limited (ASX:PEN) Releases Quarterly Cash Flow Report
Peninsula Energy Limited (ASX:PEN) releases its quarterly cash flow report, detailing cash outflows and plans for future funding.
Opthea Limited (ASX:OPT) Releases Q2 FY25 Activity Report
Opthea Limited (ASX:OPT) releases Q2 FY25 Activity Report, detailing advancements in Phase 3 trials and financial developments including a R&D tax incentive.